Page last updated: 2024-10-15

2-keto-4-methylvalerate and Growth Disorders

2-keto-4-methylvalerate has been researched along with Growth Disorders in 1 studies

alpha-ketoisocaproic acid: RN given refers to parent cpd
4-methyl-2-oxopentanoate : A 2-oxo monocarboxylic acid anion that is the conjugate base of 4-methyl-2-oxopentanoic acid.
4-methyl-2-oxopentanoic acid : A 2-oxo monocarboxylic acid that is pentanoic acid (valeric acid) substituted with a keto group at C-2 and a methyl group at C-4. A metabolite that has been found to accumulate in maple syrup urine disease.

Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zinnanti, WJ1
Lazovic, J1
Griffin, K1
Skvorak, KJ1
Paul, HS1
Homanics, GE1
Bewley, MC1
Cheng, KC1
Lanoue, KF1
Flanagan, JM1

Other Studies

1 other study available for 2-keto-4-methylvalerate and Growth Disorders

ArticleYear
Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Brain : a journal of neurology, 2009, Volume: 132, Issue:Pt 4

    Topics: Amino Acids; Animals; Behavior, Animal; Brain; Brain Edema; Brain Mapping; Dietary Proteins; Disease

2009